Acupuncture for Nasal Congestion in Allergic Rhinitis: An Open-Label, Randomized, Monocenter Trial (ANCAR Trial)
- Conditions
- nasal blockageNasal obstruction10046304
- Registration Number
- NL-OMON53405
- Lead Sponsor
- Mermaid Medicine®
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 62
• Diagnosed AR by a physician.
• Have one of the AR types: seasonal (SAR) or perennial (PAR) or mixed (MAR)
allergic rhinitis.
• VAS nasal congestion: from 3-10.
• Age: from 18 years.
• Signed Informed Consent.
• COVID-19.
• Acute common cold.
• Influenza.
• Fever (38°C or higher).
• Acute nasal trauma (such as a fracture and epistaxis).
• Irreversible nasal blockages (such as septum deviation, concha bullosa,
polyps and cysts).
• Nasal and sinus cancer.
• Pregnancy or planning for pregnancy.
• Consumed decongestions, antihistamines, antibiotics or corticosteroids within
2 weeks before the RCT.
• Received acupuncture, Chinese herbal medicine or another complementary
treatment within 2 weeks before the RCT.
• Received immunotherapy within 2 weeks before the RCT.
• Patients refusing or unable to sign Informed Consent.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method